Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Reinhardt

Showing results (101-110 of 223) with videos related to

Pageof 23
Sort By:
Scientific Reports|June 13, 2022
Screening and diagnosis of hemoglobinopathies in Germany: Current state and future perspectivesCarmen Aramayo-Singelmann, Susan Halimeh, Pia Proske, et al.
Blood|April 13, 2017
Therapy reduction in patients with Down syndrome and myeloid leukemia: the international ML-DS 2006 trialMadita Uffmann, Mareike Rasche, Martin Zimmermann, et al.
Paediatric Drugs|September 20, 2021
Managing Adverse Events Associated with Dinutuximab Beta Treatment in Patients with High-Risk Neuroblastoma: Practical GuidanceGiuseppe Barone, Ailish Barry, Francisco Bautista, et al.
Blood|September 28, 2011
Second induction with high-dose cytarabine and mitoxantrone: different impact on pediatric AML patients with t(8;21) and with inv(16)Ursula Creutzig, Martin Zimmermann, Jean-Pierre Bourquin, et al.
Annals of Hematology|January 15, 2020
Evaluation of dsDNA from extracellular vesicles (EVs) in pediatric AML diagnosticsEvangelia Kontopoulou, Sarah Strachan, Katarina Reinhardt, et al.
Biosensors & Bioelectronics|November 30, 2022
Genetically encoded dual fluorophore reporters for graded oxygen-sensing in light microscopyNadine Bauer, Ivan Maisuls, Abel Pereira da Graça, et al.
Pediatric Blood & Cancer|July 6, 2019
Phase I dose-escalation study of volasertib in pediatric patients with acute leukemia or advanced solid tumorsFrançois Doz, Franco Locatelli, André Baruchel, et al.
Cancer|August 17, 2016
Changes in cytogenetics and molecular genetics in acute myeloid leukemia from childhood to adult age groupsUrsula Creutzig, Martin Zimmermann, Dirk Reinhardt, et al.
Leukemia Research|May 4, 2010
FLT3 and KIT mutated pediatric acute myeloid leukemia (AML) samples are sensitive in vitro to the tyrosine kinase inhibitor SU11657Bianca F Goemans, Christian M Zwaan, Jacqueline Cloos, et al.
European Journal of Haematology|August 13, 2025
Prognostic Value of Molecular Genetic Measurable Residual Disease (MRD) Monitoring in Pediatric Acute Myeloid Leukemia Expressing KMT2A::MLLT10Emma Steidel, Eser Orhan, Mareike Rasche, et al.
Pageof 23

Showing results (101-110 of 223) with videos related to

Sort By:
Pageof 23
Scientific Reports|June 13, 2022
Screening and diagnosis of hemoglobinopathies in Germany: Current state and future perspectivesCarmen Aramayo-Singelmann, Susan Halimeh, Pia Proske, et al.
Blood|April 13, 2017
Therapy reduction in patients with Down syndrome and myeloid leukemia: the international ML-DS 2006 trialMadita Uffmann, Mareike Rasche, Martin Zimmermann, et al.
Paediatric Drugs|September 20, 2021
Managing Adverse Events Associated with Dinutuximab Beta Treatment in Patients with High-Risk Neuroblastoma: Practical GuidanceGiuseppe Barone, Ailish Barry, Francisco Bautista, et al.
Blood|September 28, 2011
Second induction with high-dose cytarabine and mitoxantrone: different impact on pediatric AML patients with t(8;21) and with inv(16)Ursula Creutzig, Martin Zimmermann, Jean-Pierre Bourquin, et al.
Annals of Hematology|January 15, 2020
Evaluation of dsDNA from extracellular vesicles (EVs) in pediatric AML diagnosticsEvangelia Kontopoulou, Sarah Strachan, Katarina Reinhardt, et al.
Biosensors & Bioelectronics|November 30, 2022
Genetically encoded dual fluorophore reporters for graded oxygen-sensing in light microscopyNadine Bauer, Ivan Maisuls, Abel Pereira da Graça, et al.
Pediatric Blood & Cancer|July 6, 2019
Phase I dose-escalation study of volasertib in pediatric patients with acute leukemia or advanced solid tumorsFrançois Doz, Franco Locatelli, André Baruchel, et al.
Cancer|August 17, 2016
Changes in cytogenetics and molecular genetics in acute myeloid leukemia from childhood to adult age groupsUrsula Creutzig, Martin Zimmermann, Dirk Reinhardt, et al.
Leukemia Research|May 4, 2010
FLT3 and KIT mutated pediatric acute myeloid leukemia (AML) samples are sensitive in vitro to the tyrosine kinase inhibitor SU11657Bianca F Goemans, Christian M Zwaan, Jacqueline Cloos, et al.
European Journal of Haematology|August 13, 2025
Prognostic Value of Molecular Genetic Measurable Residual Disease (MRD) Monitoring in Pediatric Acute Myeloid Leukemia Expressing KMT2A::MLLT10Emma Steidel, Eser Orhan, Mareike Rasche, et al.
Pageof 23